HIV Vaccine Research and Development - NIAID DAIDS Therapeutics Research Program
$18,825,924Y01FY2024AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
The NIAID Division of AIDS and the U.S. Military HIV Research Program (MHRP), Walter Reed Army Institute of Research (WRAIR), U.S. Army Medical Research and Development Command (MRDC) remain committed to the common objective of developing a safe and effective vaccine for HIV/AIDS. The Agencies recognize the potential utility of an HIV/AIDS vaccine in stopping the global HIV/AIDS epidemic and the need to conduct and support basic science, preclinical development, and both vaccine and non-vaccine clinical research in developing countries where the epidemic is most prevalent. This project is for support of NIAID Division of AIDS (DAIDS) Therapeutics Research Program projects.
View original record on NIH RePORTER →